Darrelp Cohen News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Darrelp cohen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Darrelp Cohen Today - Breaking & Trending Today

Viracta Therapeutics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference

Viracta Therapeutics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Darrelp Cohen , Mark Rothera , Ashleigh Barreto , Viracta Therapeutics Inc , Healthcare Life Sciences Conference On , Healthcare Life Sciences Conference , Head Of Investor Relations Corporate Communications , Annual Healthcare Life Sciences , Chief Executive Officer , Chief Medical Officer , Annual Healthcare Life Sciences Conference , Viracta Therapeutics , Relations Contact , Investor Relations ,

Viracta Therapeutics Announces New Employment Inducement Grant

Viracta Therapeutics Announces New Employment Inducement Grant
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Ashleigh Barreto , Darrelp Cohen , Compensation Committee Of Viracta Board Directors , Head Of Investor Relations Corporate Communications , Viracta Therapeutics Inc , Chief Medical Officer , Compensation Committee , Equity Incentive , Equity Incentive Plan , Inducement Plan , Nasdaq Listing Rule , Viracta Therapeutics , Relations Contact , Investor Relations ,

Viracta Therapeutics Announces New Employment Inducement Grant - Viracta Therapeutics (NASDAQ:VIRX)

SAN DIEGO, Aug. 18, 2023 (GLOBE NEWSWIRE) Viracta Therapeutics, Inc. (NASDAQ:VIRX), a clinical-stage precision oncology company focused on the treatment and prevention of virus-associated cancers that impact ....

Ashleigh Barreto , Darrelp Cohen , Compensation Committee Of Viracta Board Directors , Viracta Therapeutics Inc , Head Of Investor Relations Corporate Communications , Chief Medical Officer , Compensation Committee , Equity Incentive , Equity Incentive Plan , Inducement Plan , Nasdaq Listing Rule , Viracta Therapeutics , Relations Contact , Investor Relations ,

Viracta Therapeutics Announces Publication in Blood Advances Demonstrating Promising and Durable Signal of Nana-val Efficacy in Patients with Relapsed or Refractory (R/R) Epstein-Barr Virus-Positive (EBV+) Lymphoma

Results from Phase 1b/2 trial showed complete responses achieved and ongoing durable responses observed out to approximately 36 months across multiple EBV+ lymphoma subtypes, including some of the. ....

United States , Kathy Vincent , Darrelp Cohen , Ashleigh Barreto , Pierluigi Porcu , Globenewswire Inc , Head Of Investor Relations Corporate Communications , Division Of Hematologic Malignancies , Viracta Therapeutics Inc , Department Of Medical Oncology , Greig Communications , American Society Of Hematology , Thomas Jefferson University , Medical Oncology , Hematologic Malignancies , Hematopoietic Stem Cell Transplantation , Jefferson University , Chief Medical Officer , Nana Val Phase , Private Securities Litigation Reform Act , Relations Contact , Investor Relations ,

Viracta Therapeutics Appoints Darrel P. Cohen, M.D., Ph.D. as Chief Medical Officer

SAN DIEGO, Aug. 07, 2023 Viracta Therapeutics, Inc. , a clinical-stage precision oncology company focused on the treatment and prevention of virus-associated cancers that impact patients. ....

Ashleigh Barreto , Darrelp Cohen , Mark Rothera , Kathy Vincent , Viracta Therapeutics Inc , Greig Communications , Georgetown University Medical Center , Biosight Pharmaceuticals , Phase Clinical Development At Pfizer Oncology , Leadership Team , Head Of Clinical Development , Globenewswire Inc , Duke University Medical Center , Cell Therapy At Athenex Inc , Head Of Investor Relations Corporate Communications , Boston University School Of Medicine , Chief Medical Officer , Executive Leadership , Chief Executive Officer , Athenex Inc , Clinical Development , Vice President , Phase Clinical Development , Pfizer Oncology , University School , Internal Medicine ,